Indications for: Dorzolamide
Open-angle glaucoma. Ocular hypertension.
Adults and Children:
1 drop 3 times daily.
Discontinue if ocular effects (eg, conjunctivitis, lid reactions) occur. Low endothelial cell counts. Contact lenses: remove prior to administration; may reinsert 15mins after dose. Hepatic impairment. Severe renal impairment (CrCl <30mL/min): not recommended. Pregnancy. Nursing mothers.
Carbonic anhydrase inhibitor (sulfonamide).
Concomitant oral carbonic anhydrase inhibitors: not recommended. May increase salicylate toxicity (acidosis).
Burning, stinging, bitter taste, punctate keratitis, ocular allergic reaction, blurred vision, tearing, dryness, photophobia; corneal edema, possible sulfa-like systemic effects.
Formerly known under the brand name Trusopt.